TABLE 3.
Positive detection rate of different categories of subjects tested by A2 assay.
| Group | Pos./Tested (%) | ||
|---|---|---|---|
| PL | CRC | NED | |
| Age | |||
| <55 | 12/24 (50.0) | 24/30 (80.0) | 12/118 (10.2) |
| ≥55 | 10/16 (62.5) | 38/45 (84.4) | 5/53 (9.4) |
| Gender | |||
| Male | 13/27 (48.2) | 44/54 (81.5) | 6/74 (8.1) |
| Female | 9/13 (69.2) | 18/21 (85.7) | 11/97 (11.3) |
| Location | |||
| Right‐side | 17/19 (89.5) | ||
| Left‐side | 45/56 (80.4) | ||
| Stage | |||
| NA | 14/29 (48.3) | ||
| AA | 8/11 (72.7) | ||
| Stage I | 5/7 (71.4) | ||
| Stage II | 14/19 (73.7) | ||
| Stage III | 15/18 (83.3) | ||
| Stage IV | 3/3 (100.0) | ||
| Unknown stage | 25/28 (89.3) | ||
| Total stage | 84/115 (73.0) | ||
Abbreviations: AA, advanced adenoma; CRC, colorectal cancer; NA, non‐advanced adenoma; PL, precancerous lesions.